Investing.com - ICU Medical (NASDAQ: ICUI) reported fourth quarter EPS of $1.57, $0.36 better than the analyst estimate of $1.21. Revenue for the quarter came in at $587.86M versus the consensus estimate of $561.9M.
Guidance
ICU Medical sees FY 2024 EPS of $4.40-$5.10 versus the analyst consensus of $5.18.
ICU Medical's stock price closed at $106.81. It is up 16.94% in the last 3 months and down -37.41% in the last 12 months.
ICU Medical saw 0 positive EPS revisions and 2 negative EPS revisions in the last 90 days. See ICU Medical's stock price’s past reactions to earnings here.
According to InvestingPro, ICU Medical's Financial Health score is "good performance".
Check out ICU Medical's recent earnings performance, and ICU Medical's financials here.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar